Table 4.
Multivariate-adjusted relationship between various characteristics and blood pressure status of participants categorized by body mass index
| Body mass index category < 21.0 kg/m2 N = 216 | Body mass index category ≥ 21.0 kg/m2 N = 601 | |||
|---|---|---|---|---|
| Systolic blood pressure | Diastolic blood pressure | Systolic blood pressure | Diastolic blood pressure | |
| Characteristics N = 817 | β(P-value)§ | β(P-value)§ | β(P-value)§ | β(P-value)§ |
| Age | 0.375 (< 0.001) | 0.065 (0.396) | 0.275 (< 0.001) | −0.045 (0.332) |
| Body mass index | – | – | 0.175 (< 0.001) | 0.141 (0.001) |
| Alcohol consumption | 0.124 (0.064) | – | – | −0.046 (0.247) |
| Smoking status | 0.175 (0.010) | 0.182 (0.014) | 0.114 (0.006) | 0.102 (0.020) |
| History of CVD (Yes = 1, No = 0) | – | – | – | −0.042 (0.307) |
| Triglycerides | – | – | – | 0.064 (0.167) |
| HDL cholesterol | – | – | – | 0.083 (0.067) |
| LDL cholesterol | – | 0.162 (0.018) | – | – |
| Antilipidemic medication (Yes = 1, No = 0) | – | – | − 0.090 (0.020) | – |
| Fasting plasma glucose | 0.151 (0.020) | 0.087 (0.197) | 0.088 (0.024) | – |
| Antiidiabetic medication (Yes = 1, No = 0) | – | − 0.060 (0.370) | – | −0.041 (0.302) |
| Serum uric acid | 0.178 (0.011) | 0.155 (0.028) | −0.127 (0.001) | −0.102 (0.019) |
| Estimated GFR | 0.272 (< 0.001) | 0.170 (0.030) | – | − 0.036 (0.429) |
| Aspartate transaminase | – | − 0.086 (0.243) | – | – |
| γ-glutamyl transpeptidase | – | 0.243 (0.002) | 0.124 (0.007) | 0.157 (0.001) |
| R2 | 0.167 (< 0.001) | 0.163 (< 0.001) | 0.127 (< 0.001) | 0.084 (< 0.001) |
Only factors remained in the final model were shown. Data for triglycerides, fasting plasma glucose, aspartate transaminase, and γ-glutamyl transpeptidase were skewed and were log-transformed for analysis. Bolded numbers indicate significance
β standard coefficient, R2 coefficient of determination
§Multivariate adjusted for all confounding factors in Table 1 by multiple linear regression analysis using backward elimination method